首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

到 2030 年北美分子診斷市場預測 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶

市場調查報告書

商品編碼

1452578

到 2030 年北美分子診斷市場預測 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶

North America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日期: 2024年01月05日 | 出版商:

The Insight Partners | 英文 125 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美分子診斷市場預計將從2022年的80.5648億美元成長到2030年的207.4038億美元。預計2022年至2030年CAGR為12.5%。

新產品的開發和即時檢測需求的增加推動了北美分子診斷市場

即時檢測是醫學的一個分支，其分析範圍和臨床應用不斷發展。即時檢測解決方案提供者提供各種評估的產品，從血糖測量到黏彈性凝血測定。這些測試消除了運輸和製備臨床樣本的時間，使專業人員能夠在更短的時間內做出額外測試或治療的臨床決策。這種新興的醫療保健解決方案正在被患者和醫療保健服務提供者積極採用。即時檢測廣泛用於治療、診斷和患者監測等應用。此外，即時照護產品和服務可協助醫療保健提供者滿足病患對居家醫療照護的需求。事實證明，這些產品和服務在 COVID-19 大流行期間特別有用，它們允許患者在家中接受檢測，而不是前往診斷或治療機構，從而降低感染風險。因此，對現場檢測的需求不斷成長有利於分子診斷市場。

北美分子診斷市場概況

北美分子診斷市場已細分為美國、加拿大和墨西哥。技術先進產品的日益採用、研發活動的增加、大型醫療保健企業的存在以及分子診斷的使用不斷增加是推動該地區分子診斷市場成長的關鍵因素。 2022年，美國佔據北美分子診斷市場最大佔有率。

北美分子診斷市場收入及 2030 年預測（百萬美元）

北美分子診斷市場細分

北美分子診斷市場分為疾病領域、技術、產品和服務、最終用戶和國家。

根據疾病領域，北美分子診斷市場分為傳染病、腫瘤、基因檢測、心臟病、免疫系統疾病等。 2022 年，傳染病細分市場佔據北美分子診斷市場佔有率最大的佔有率。

根據技術，北美分子診斷市場分為聚合酶鍊式反應（PCR）、原位雜合技術、等溫核酸擴增技術（INAAT）、DNA定序和下一代定序（NGS）、DNA微陣列等。聚合酶鍊式反應 (PCR) 領域在 2022 年佔據了北美最大的分子診斷市場佔有率。聚合酶鍊式反應 (PCR) 進一步細分為 RT-PCR、qPCR、多重 PCR 等。

根據產品和服務，北美分子診斷市場分為檢測和試劑盒、儀器、服務和軟體。 2022 年，檢測和試劑盒領域佔據了北美最大的分子診斷市場。

根據最終用戶，北美分子診斷市場分為診斷實驗室、醫院和診所、研究和學術機構等。 2022 年，診斷實驗室領域佔據北美最大的分子診斷市場。

依國家分類，北美分子診斷市場分為美國、加拿大和墨西哥。 2022年，美國將主導北美分子診斷市場。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AG 和TBG Diagnostics Limited 是在這些領域營運的一些領先公司。北美分子診斷市場。

Point-of-care testing is a branch of medicine with a rapidly evolving analytical scope and clinical application. Point-of-care testing solution providers offer products for various evaluations, ranging from blood glucose measurement to viscoelastic coagulation assays. Eliminating the time of transportation and preparation of clinical samples, these tests enable professionals to make clinical decisions about additional testing or therapy in less time. This emerging healthcare solution is being aggressively adopted by patients and healthcare service providers. Point-of-care assays are extensively used in therapeutics, diagnostics, and patient monitoring applications, among others. Moreover, point-of-care products and services help healthcare providers in meeting patients' demand for at-home medical care. These products and services proved specifically helpful during the COVID-19 pandemic by allowing patients to take tests from their homes instead of traveling to diagnostic or treatment facilities, thereby lowering the risk of infection. Thus, the rising demand for point-of-care testing benefits the molecular diagnostics market.

North America Molecular Diagnostics Market Overview

The North America molecular diagnostics market has been segmented into the US, Canada, and Mexico. The increasing adoption of technologically advanced products, rise in research & development activities, presence of large healthcare businesses, and growing use of molecular diagnostics are among the key factors propelling the growth of the molecular diagnostics market in this region. The US held the largest share of the North America molecular diagnostics market in 2022.

North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

North America Molecular Diagnostics Market Segmentation

The North America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the North America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest North America molecular diagnostics market share in 2022.

Based on technology, the North America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest North America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further subsegmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the North America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest North America molecular diagnostics market share in 2022.

Based on end users, the North America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest North America molecular diagnostics market share in 2022.

Based on country, the North America molecular diagnostics market has been categorized into the US, Canada, and Mexico. The US dominated the North America molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the North America molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis

5. North America Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - North America Market Analysis

6.1 North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Molecular Diagnostics Market - Country Analysis

11.1 North America Molecular Diagnostics Market, Revenue and Forecast To 2030
- 11.1.1 Overview
  - 11.1.1.1 North America Molecular Diagnostics Market, by Country
- 11.1.2 US
  - 11.1.2.1 Overview
- 11.1.3 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 US Molecular Diagnostics Market, by Disease Area
- 11.1.5 US Molecular Diagnostics Market, by Technology
  - 11.1.5.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
- 11.1.6 US Molecular Diagnostics Market, by Product and Services
- 11.1.7 US Molecular Diagnostics Market, by End User
- 11.1.8 Canada
  - 11.1.8.1 Overview
- 11.1.9 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Canada Molecular Diagnostics Market, by Disease Area
- 11.1.11 Canada Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Canada Molecular Diagnostics Market, by Product and Services
- 11.1.13 Canada Molecular Diagnostics Market, by End User
- 11.1.14 Mexico
  - 11.1.14.1 Overview
- 11.1.15 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 Mexico Molecular Diagnostics Market, by Disease Area
- 11.1.17 Mexico Molecular Diagnostics Market, by Technology
  - 11.1.17.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 Mexico Molecular Diagnostics Market, by Product and Services
- 11.1.19 Mexico Molecular Diagnostics Market, by End User

12. North America Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. North America Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Qiagen NV
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 bioMerieux SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novartis AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 TBG Diagnostics Limited
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Molecular Diagnostics Market Segmentation
Table 2. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 3. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 4. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 6. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 7. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 9. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 12. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 13. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 14. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. North America - PEST Analysis
Figure 2. North America Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Molecular Diagnostics Market, 2022 ($Mn)
Figure 33. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)